Narcolepsy Drugs Market Size, Share, Growth Analysis, By Disease Type(Daytime Extreme Sleepiness, Cataplexia, and Other Disease Type), By Therapeutics Type(Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor), By Region - Industry Forecast 2024-2031

Global Narcolepsy Drugs Market size was valued at around USD 3.4 billion in 2022 and is expected to rise from USD 3.7 billion in 2023 to reach a value of USD 7 billion by 2031, at a CAGR of 9.5% over the forecast period (2024–2031).

Increasing awareness regarding mental health and rising prevalence of multiple sleep disorders are projected to alter the global narcolepsy drugs market growth in the future. Rising number of people being diagnosed with narcolepsy, high investments in the development of novel narcolepsy drugs, and increasing demand for lifestyle improvement are key factors promoting the sales of narcolepsy drugs going forward. Expedition of the approval process for narcolepsy drugs by regulatory bodies and governments to satisfy the unmet medical needs of patients are also estimated to create new opportunities for narcolepsy drug companies in the long run. Moreover, advancements in drug discovery and development technologies are also expected to benefit the adoption of narcolepsy drugs on a global level. On the contrary, lack of awareness, side effects associated with the use of narcolepsy drugs, and competition from non-pharmacological therapies and treatments are slated to slow down narcolepsy drug demand across the study period and beyond.

US Narcolepsy Drugs Market  is poised to grow at a sustainable CAGR for the next forecast year.